Results 221 to 230 of about 1,321,882 (316)
Diffusion Tractography Biomarker for Epilepsy Severity in Children With Drug‐Resistant Epilepsy
ABSTRACT Objective To develop a novel deep‐learning model of clinical DWI tractography that can accurately predict the general assessment of epilepsy severity (GASE) in pediatric drug‐resistant epilepsy (DRE) and test if it can screen diverse neurocognitive impairments identified through neuropsychological assessments.
Jeong‐Won Jeong +7 more
wiley +1 more source
Comparative analysis of AI and expert evaluations in engineering design pedagogy. [PDF]
Coşkun TK, Altan EB.
europepmc +1 more source
Optimization of Building Design Based on Wind Engineering - Tachikawa General Hospital -
Shozo Kitahara, Naoko Konno
openalex +2 more sources
ABSTRACT Background Neurodegeneration with brain iron accumulation (NBIA) comprises a genetically and clinically heterogeneous group of rare neurological disorders characterized particularly by iron accumulation in the basal ganglia. To date, 15 genes have been associated with NBIA.
Seda Susgun +95 more
wiley +1 more source
Prediction of preterm birth from cervical length measurements in twin pregnancies using machine learning. [PDF]
Costanzo A +3 more
europepmc +1 more source
The General Mathematical Model for the Production Engineering (ProMAT)
Illés Dudás
openalex +1 more source
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta +18 more
wiley +1 more source
Corrigendum to: real-time and noninvasive tracking of injectable hydrogel degradation using functionalized AIE nanoparticles. [PDF]
Zhang M +8 more
europepmc +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source

